Ketolainen J - Search Results

1

Parameter optimization in a continuous direct compression process of commercially batch-produced bisoprolol tablets.

Lyytikäinen J, Stasiak P, Kubelka T, Olenius T, Korhonen O, Ketolainen J, Ervasti T. Lyytikäinen J, et al. Among authors: ketolainen j. Int J Pharm. 2022 Nov 25;628:122355. doi: 10.1016/j.ijpharm.2022.122355. Epub 2022 Oct 29. Int J Pharm. 2022. PMID: 36341918 Free article.

2

Surface-active derivative of inulin (Inutec® SP1) is a superior carrier for solid dispersions with a high drug load.

Srinarong P, Hämäläinen S, Visser MR, Hinrichs WL, Ketolainen J, Frijlink HW. Srinarong P, et al. Among authors: ketolainen j. J Pharm Sci. 2011 Jun;100(6):2333-42. doi: 10.1002/jps.22471. Epub 2011 Jan 19. J Pharm Sci. 2011. PMID: 21254065

3

Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).

Aksu B, De Beer T, Folestad S, Ketolainen J, Lindén H, Lopes JA, de Matas M, Oostra W, Rantanen J, Weimer M. Aksu B, et al. Among authors: ketolainen j. Eur J Pharm Sci. 2012 Sep 29;47(2):402-5. doi: 10.1016/j.ejps.2012.06.009. Epub 2012 Jun 26. Eur J Pharm Sci. 2012. PMID: 22749874

4

Taking PAT to the next level.

Ciurczak EW, Ketolainen J, Laitinen R, Aaltonen J, Lindén HH. Ciurczak EW, et al. Among authors: ketolainen j. Eur J Pharm Sci. 2011 Jan 18;42(1-2):1-2. doi: 10.1016/j.ejps.2010.10.009. Epub 2010 Oct 30. Eur J Pharm Sci. 2011. PMID: 21040783

5

Effect of cocrystallization techniques on compressional properties of caffeine/oxalic acid 2:1 cocrystal.

Aher S, Dhumal R, Mahadik K, Ketolainen J, Paradkar A. Aher S, et al. Among authors: ketolainen j. Pharm Dev Technol. 2013 Feb;18(1):55-60. doi: 10.3109/10837450.2011.618950. Epub 2011 Oct 10. Pharm Dev Technol. 2013. PMID: 21981663

6

Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions.

Suihko E, Poso A, Korhonen O, Gynther J, Ketolainen J, Paronen P. Suihko E, et al. Among authors: ketolainen j. Pharm Res. 2000 Aug;17(8):942-8. doi: 10.1023/a:1007523103979. Pharm Res. 2000. PMID: 11028939

7

Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.

Suihko E, Korhonen O, Järvinen T, Ketolainen J, Jarho P, Laine E, Paronen P. Suihko E, et al. Among authors: ketolainen j. Int J Pharm. 2001 Mar 14;215(1-2):137-45. doi: 10.1016/s0378-5173(00)00682-7. Int J Pharm. 2001. PMID: 11250099

8

Dynamic solid-state and tableting properties of four theophylline forms.

Suihko E, Lehto VP, Ketolainen J, Laine E, Paronen P. Suihko E, et al. Among authors: ketolainen j. Int J Pharm. 2001 Apr 17;217(1-2):225-36. doi: 10.1016/s0378-5173(01)00607-x. Int J Pharm. 2001. PMID: 11292558

9

Effects of physical properties for starch acetate powders on tableting.

Korhonen O, Pohja S, Peltonen S, Suihko E, Vidgren M, Paronen P, Ketolainen J. Korhonen O, et al. Among authors: ketolainen j. AAPS PharmSciTech. 2002;3(4):E34. doi: 10.1208/pt030434. AAPS PharmSciTech. 2002. PMID: 12916928 Free PMC article.

10

Evaluation of novel starch acetate-diltiazem controlled release tablets in healthy human volunteers.

Korhonen O, Kanerva H, Vidgren M, Urtti A, Ketolainen J. Korhonen O, et al. Among authors: ketolainen j. J Control Release. 2004 Mar 24;95(3):515-20. doi: 10.1016/j.jconrel.2003.12.026. J Control Release. 2004. PMID: 15023462 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page